Chlamydia pneumoniae IgG seropositivity and risk of deep-vein thrombosis

Ted Koster; Frits R. Rosendaal; DD Lieuw-A-Len; Aloys C.M. Kroes; J Emmerich; JT van Dissel

doi:10.1016/s0140-6736(00)02244-3

Abstract

1 min read

In a population-based case-control study of 474 patients with a first episode of deep-vein thrombosis and 474 age-matched and sex-matched controls, we found no effect of Chlamydia pneumoniae infection on the occurrence of deep-vein thrombosis.

Related publications

Article1996

Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis

Martin den Heijer, Ted Koster, Henk J. Blom, Gerard M.J. Bos, Ernest Briët, Pieter H. Reitsma, Jan P. Vandenbroucke, Frits R. Rosendaal

New England Journal of Medicine

Article2000

Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis

Nico H. van Tilburg, Frits R. Rosendaal, Rogier M. Bertina

Blood

Article2002

Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis

Benien E. van Aken, Pieter H. Reitsma, Frits R. Rosendaal

British Journal of Haematology

Article1998

Hemostatic Effects of Oral Contraceptives in Women who Developed Deep-vein Thrombosis while Using Oral Contraceptives

Kitty W.M. Bloemenkamp, Frans M. Helmerhorst, Ted Koster, Rogier M. Bertina, Jan P. Vandenbroucke, Frits R. Rosendaal

Thrombosis and Haemostasis

Article2007

Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis

Astrid van Hylckama Vlieg, Ramón Montes, Frits R. Rosendaal, José Hermida

Journal of Thrombosis and Haemostasis